1991
DOI: 10.1152/ajpheart.1991.261.2.h598
|View full text |Cite
|
Sign up to set email alerts
|

A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts

Abstract: Detailed characteristics of a new bioassay method for detection and quantification of endothelium-derived relaxing factor (EDRF) are described. Guanosine 3',5'-cyclic monophosphate (cGMP) responses of RFL-6 rat fetal lung fibroblast cells were utilized to estimate the activity of nitric oxide (NO) and EDRF. The conditioned medium from bovine aortic endothelial (BAE) cells cultured in tissue culture plates was quickly transferred to RFL-6 incubations to determine EDRF. In the presence of superoxide dismutase, R… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
76
0
1

Year Published

1993
1993
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 66 publications
(77 citation statements)
references
References 0 publications
0
76
0
1
Order By: Relevance
“…Thus, allosteric inhibition of sGC is mediated by a regulatory purine nucleotide binding site formed by residues in the ␣ and ␤ subunits that preferentially binds ATP compared to GTP, in contrast to the rigid nucleotide specificity of the substrate catalytic site. The role of sGC as an intracellular sensor of ATP, coupling metabolic and energetic fluxes to NO-dependent signaling was examined by using RFL-6 cells, a particularly responsive model of NO-induced [GMP] i accumulation (27). Regulation of sGC by [ATP] i , rather than extracellular ATP, was highlighted by the inability of ATP to alter [cGMP] i accumulation in response to SNP when added to intact RFL-6 cells, reflecting the impermeability of the plasma membrane to polyanionic nucleotides (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Thus, allosteric inhibition of sGC is mediated by a regulatory purine nucleotide binding site formed by residues in the ␣ and ␤ subunits that preferentially binds ATP compared to GTP, in contrast to the rigid nucleotide specificity of the substrate catalytic site. The role of sGC as an intracellular sensor of ATP, coupling metabolic and energetic fluxes to NO-dependent signaling was examined by using RFL-6 cells, a particularly responsive model of NO-induced [GMP] i accumulation (27). Regulation of sGC by [ATP] i , rather than extracellular ATP, was highlighted by the inability of ATP to alter [cGMP] i accumulation in response to SNP when added to intact RFL-6 cells, reflecting the impermeability of the plasma membrane to polyanionic nucleotides (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…For flow cytometry, Abs against human CD2 (6F10.3), CD14 (RM052), CD19 (J4.119), CD80 (MAB104), CD83 (HB15A) (all Beckmann Coulter, Krefeld, Germany), CD86 (BU63, Serotec, Oxford, U.K.), HLA-DR (YD1/ 63.4.10, Serotec), nNOS (nNOS-AB, A-11, Santa Cruz Biotechnology, Santa Cruz, CA), CD40 (5c3), CD208-APC (110-1112) (all Becton Dickinson), CCR7-APC (150503; R&D Systems, Wiesbaden, Germany), mouse (MOPC-31-C, MOPC-173, [27][28][29][30][31][32][33][34][35], and rat (R35-95, MOPC-21) subclassspecific isotypes (all Beckmann Coulter) were used. Conjugated secondary reagents: FITC-conjugated goat-anti-rat-IgG (Biozol, Eching, Germany), PE-conjugated donkey anti-mouse-IgG (Jackson ImmunoResearch Laboratories, Suffolk, U.K.), for myeloid DC: anti-CD1c-PE (M241, Ancell, Cologne, Germany).…”
Section: Absmentioning
confidence: 99%
“…The cGMP content of the RFL-6 cells was determined by RIA as described previously (27). Basal cGMP values measured in RFL-6 cells incubated under the same conditions but not exposed to DCs were subtracted from the experimental values.…”
Section: Rfl-6 Reporter Cell Assaymentioning
confidence: 99%
“…A large body of experimental evidence bears out this assumption. For example, endothelial nitric oxide can be detected extracellularly by either electrochemical means [1] or by using a reporter cell system [2]. It has been suggested repeatedly that nitric oxide requires a carrier system in order to reach its pharmacological destination because of its inherently high reactivity with oxygen [3].…”
Section: Introductionmentioning
confidence: 99%